Dear Editor,
Milk fat globule epidermal growth factor 8 (MFG-E8) (also known as lactadherin) is a secreted glycoprotein, and consists of two EGF-like domains, a mucin-like domain, and tandem discoidin-like domains (C-domains); in addition, an RGD motif that binds to αVβ3 and αVβ5 integrins is present in the second EGF domain.1 The C2 domain of MFG-E8 shares homology with the lipid-binding domains of blood coagulation factors VIII and V that have been shown to mediate Ca2+-independent, high affinity (Kd∼2 nM) binding to phosphatidylserine (PS).2 Similarly, MFG-E8 is known to bind to PS via its C2 domain.3 Apoptotic cells express PS on the cell surface, and recent studies have suggested that MFG-E8 may act as a ‘bridging’ molecule that links apoptotic cells to phagocytes via its C1C2 domain and integrin-binding motif, respectively.4 However, MFG-E8 binding to phospholipids was not examined in detail. We have previously documented the occurrence of cell surface externalization of oxidized PS (PS-OX) during apoptosis, and have provided evidence that both species of PS (oxidized and nonoxidized) function as recognition signals for macrophages.5, 6 We now show that MFG-E8 preferentially interacts with PS-OX and, to a lesser degree, with nonoxidized PS and PC (phosphatidylcholine).
To determine the pattern of MFG-E8 binding to phospholipids, ELISA plates were coated with various phospholipids and incubated with recombinant, FLAG-tagged MFG-E8. As shown in Figure 1a, MFG-E8 bound preferentially to PS (i.e. two-fold more binding as compared with PC). Binding to other phospholipids (phosphatidylinositol, PI; phosphatidylethanolamine, PE; phosphatidylglycerol, PG) was negligible, even at higher concentrations of FLAG-tagged protein. We then asked whether MFG-E8 binds to immobilized PS-OX. To this end, PS was oxidized prior to addition to the microtitre plate using Fe2+/tert-butylhydroperoxide (THP); approximately 60% of the PS molecules were determined to be oxidized by this method (Figure 1b). Quantification of the amount of MFG-E8 bound to the wells revealed a preferential binding of MFG-E8 to PS-OX as compared to nonoxidized PS (Figure 1c). Although the degree of binding of MFG-E8 to individual oxidation products of PS was not determined, our mass spectroscopic analyses revealed that PS hydroperoxides were dominating among the oxidation products (Figure 1b).
To validate our observations, binding of MFG-E8 to small unilamellar liposomes (SUVs) was determined by quenching of fluorescence of NBD-PC incorporated into the liposomes. NBD fluorescence is extremely sensitive to alterations in the local environment, and changes of NBD-PC fluorescence caused by lipid segregation or interactions with amino-acid groups can thus be detected upon protein attachment to the SUVs. As shown in Figure 1d, there was a considerable decay in NBD-PC fluorescence upon addition of MFG-E8 to PS-containing SUVs. Quenching was insensitive to the presence of Ca2+ (data not shown). Moreover, quenching of fluorescence was dependent on the phospholipid composition of the SUVs (PC>PC/PS>PC/PS-OX), as well as on the amount of MFG-E8 (Figure 1e). Importantly, the quenching curves were nonlinear and saturable, and therefore suggestive of binding curves. Taken together, these data show that MFG-E8 interaction with liposomes containing PS-OX is more pronounced than with the PS-expressing vehicles.
Quenching of NBD-PC fluorescence in SUVs could depend on dynamic (collisional) or static (complex formation) mechanisms. Based on the assumption of dynamic quenching with partially available fluorophore, our quenching data can be described by the Stern–Volmer law as F0/(F0−F)=1/fa+1/(faK[Mt]) where K is a dynamic quenching constant and fa is the fraction of total fluorophore accessible to the quencher (MFG-E8). As seen in Figure 1f, dependence of F0/(F0−F) on 1/[Mt] (i.e. the inverse protein concentration) is essentially linear, thus making it possible to derive values for fa and K. Our analyses reveal that the fa values for the different liposomes were not significantly different and on an average were equal to 0.53. This indicates that the fraction of phospholipids located in the outer leaflet of the SUV and involved in interactions with MFG-E8 is slightly higher than the corresponding fraction in the inner leaflet. The quenching constants were calculated to be in the range of 3 × 109–7 × 109 M−1. The lifetime (τ) of exited NBD-labeled phospholipids in membrane bilayers is approximately 4–6 ns7 and the established relationship (K=Kq × τ) between K, τ and quenching rate (Kq) thus yields a Kq in the range of 1017–1018 M−1 s−1. These values greatly exceed the diffusion rates (<1010 M−1 s−1) for small molecules, suggesting a static nature of NBD-PC quenching; in other words, our results are likely to reflect direct binding of MFG-E8 to PC, PS, and PS-OX, respectively.
We further analyzed our data based on the noncooperative model of protein binding to liposomes of different composition.8 Several assumptions were made for these calculations: all phospholipids including the fluorescent probe are distributed equally between the inner and outer bilayer and are distributed homogenously within the same bilayer, and the number of binding sites on the protein (n) is independent of the type of phospholipid. In addition, we did not discriminate between the dissociation constant (Kd) of particular classes of phospholipids, but considered Kd values for different types of liposomes (KdPC, KdPC/PS, and KdPC/PS/PS-OX). The most satisfying fitting of quenching curves for all types of liposomes and all experimental data reported in Figure 1f was found at n=550 and the following values for Kd: KdPC=3.9 μ M; KdPC/PS=1.6 μ M; KdPC/PS/PS-OX=0.6 μ M (here, n is relatively large because it corresponds to the number of phospholipid molecules interacting with one protein, as opposed to the actual number of binding sites on the protein). Thus, MFG-E8 can be estimated to bind 8–20-fold stronger to PS-OX and 2.5–4-fold stronger to PS as compared with PC.
MFG-E8 was identified as one of the most abundant proteins of membranes of milk fat globules in human milk,1 and is known to be expressed in the lactating mammary gland as well as in various other tissues.2 Moreover, recent studies have shown that thioglycolate-elicited macrophages and phagocytic-competent immature dendritic cells express MFG-E8, and it was suggested that MFG-E8 serves as an opsonin for apoptotic cells by recognizing phospholipids such as PS.4, 9 The current experiments indicate that MFG-E8 binds to PC as well as to PS, albeit with higher affinity for PS. However, the specificity of this binding may not be sufficient to explain recognition of apoptotic cells by macrophages. PS-OX represents a significantly more favorable site for MFG-E8 interaction with lipid bilayers as compared to other phospholipids. Therefore, oxidatively modified phospholipids, such as PS-OX, may serve as preferential ligands for MFG-E8. Exposure of PS-OX during apoptosis could thus promote clearance of cell corpses at least in part through interaction with the ‘bridging’ molecule, MFG-E8. Moreover, since the overall binding affinity reported herein of MFG-E8 for PS is not as strong as for other PS-binding proteins (e.g. annexin V and factor VIII), it is conceivable that phospholipids are not the sole ligands for MFG-E8. Indeed, MFG-E8 could bind to another molecule(s) on the surface of apoptotic cells, thus increasing the stability of the protein–membrane interaction (for comparison, β2-glycoprotein I, a phospholipid-binding protein, has been shown to interact with annexin II on endothelial cells10). One candidate for such a cofactor is annexin I, a cytosolic protein that is recruited to the cell surface during apoptosis, and colocalizes with PS in discrete membrane patches.11 Further studies are required to determine the full spectrum of putative apoptosis-specific binding partners of MFG-E8.
References
Stubbs JD et al. (1990) Proc. Natl. Acad. Sci. USA 87: 8417–8421
Shi J and Gilbert GE (2003) Blood 101: 2628–2636
Andersen MH et al. (2000) Biochemistry 39: 6200–6206
Hanayama R et al. (2002) Nature 417: 182–187
Kagan VE et al. (2002) J. Immunol. 169: 487–499
Arroyo A et al. (2002) J. Biol. Chem. 277: 49965–49975
Lee J and Lentz BR (1997) Biochemistry 36: 6251–6259
Gilbert GE, Furie BC and Furie B (1990) J. Biol. Chem. 265: 815–822
Akakura S et al. (2004) Exp. Cell Res. 292: 403–416
Ma K et al. (2000) J. Biol. Chem. 275: 15541–15548
Arur S et al. (2003) Dev. Cell 4: 587–598
Iverson SL et al. (2004) J. Biol. Chem. 279: 1100–1107
Acknowledgements
We thank Dr. Shigekazu Nagata for the generous provision of MFG-E8-FLAG cDNA. This study was supported by grants from the National Institutes of Health, the Swedish Research Council, the Swedish Society for Medical Research, the Shizu Matsumura Foundation, and the Jeansson Foundation. GGB was the recipient of a postdoctoral fellowship from NINDS/WHO.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Borisenko, G., Iverson, S., Ahlberg, S. et al. Milk fat globule epidermal growth factor 8 (MFG-E8) binds to oxidized phosphatidylserine: implications for macrophage clearance of apoptotic cells. Cell Death Differ 11, 943–945 (2004). https://doi.org/10.1038/sj.cdd.4401421
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401421
This article is cited by
-
The Characteristics of Macrophage Heterogeneity in Atherosclerotic Aortas
Journal of Cardiovascular Translational Research (2023)
-
Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
Scientific Reports (2019)
-
Identification and functional characterization of lactadherin, an agglutinating glycoprotein from the chordate Styela clava
In Vitro Cellular & Developmental Biology - Animal (2019)
-
AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis
Scientific Reports (2018)
-
Innate sensing of oxidation-specific epitopes in health and disease
Nature Reviews Immunology (2016)